Helps promote natural healing.

Ridgecrest Herbals® ClearLungs® Extra Strength

• Supports free breathing
• Keep airway open
• Balance mucus levels
• Maximum potency
• 200 mg

• Immune Support*
• Vertical Spray
• Actively charged: As corroborated by a university study, Sovereign Silver® contains 96% actively charged silver particles (Ag+), at least 34 times more powerful than other brands.
• Easily Absorbed: Sovereign Silvers® unprecedented particle size of 0.0008 microns (validated by Transmission Electron Microscopy) allows for easy absorption into and excretion from the cells and body.
• Less is more: Our ultra-small particle size also results in a greater silver surface area. Thats why even with a low concentration of 10 ppm, Sovereign Silver® is still much more effective than brands that contain 500 ppm!
• Perfectly Safe: Sovereign Silver® is formulated to be safe for the whole family. Taken 7x a day for 70 years, Sovereign Silver® still falls below the EPA daily Oral Silver Reference Dose (Rfd).**
• 99.999% Pure: Sovereign Silver® has only two ingredients: silver and pharmaceutical-grade purified water. It does not contain added salts or proteins that render other silver products ineffective. Plus, it is packaged in non-leaching glass bottles.
• For thousands of years, silver has played an essential role in safeguarding human health. In fact, until 1938, colloidal silver was the preferred choice of physicians for empowering the immune system and stimulating the bodys innate healing processes.**
• Today, as more people embrace natural ways to maintain their health and well-being, silver is experiencing a resurgence in popularity. And Sovereign Silver® is leading the way. By developing technologically advanced refinements in the production of silver colloids, Sovereign Silvers® Bio-Active Silver Hydrosol™ delivers advantages no other manufacturer can match.**

Kinoko Gold AHCC

Significantly Improves Immune Responses

Enhances Function of NK Cells, DC Cells, T Cells, Macrophages and Cytokines

AHCC is backed by over 25 clinical and in vivo studies published in peer-reviewed medical journals and by more than 50 human studies documented in papers and case reports. Research on AHCC has been conducted at highly reputable medical institutions such as the Yale Medical School, Harvard-affiliated Faulkner Hospital and U.T.M.D. Anderson. Several trials - including a 269-subject study published in the Journal of Hepathology, a double-blind, placebo-controlled published trial on healthy adults and a Yale Medical School study on healthy elderly patients - have shown that AHCC can increase the number of activity of:

• Natural killer (NK) cells, the body's first line of defense
• Dendritic cells, which initiate adaptive immune response
• T cells, which provide backup to NK cells
• Macrophages, which clean up cellular debris
• Cytokines, which activate the immune system